Astellas Pharma Inc. ( ALPMY) - Stock Earnings
ALPMY Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 4, 2026, midnight | — / — | — | — / — | — |
ALPMY Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 652.0 million USD | 3.7 billion USD |
| 2026Q1 | 362.9 million USD | 4.1 billion USD |
| 2026Q2 | 882.6 million USD | 4.0 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
ALPMY Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 112.6 million USD | 10.6 billion USD |
| 2025 | 339.8 million USD | 12.8 billion USD |
| 2026 | 1.9 billion USD | 14.2 billion USD |
| 2026 Est. | — | — |
ALPMY
Price: $16.19
Dividend Yield: 3.06%
Forward Dividend Yield: 6.33%
Dividend Per Share: 1.03 USD
Earnings Per Share: 1.32 USD
P/E Ratio: 12.24
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - General
Market Capitalization: 29.0 billion
Average Dividend Frequency: 4
Years Paying Dividends: 18
DGR3: -13.53%
DGR5: -5.14%
DGR10: 4.71%